Literature DB >> 2905620

Demonstration of calcitonin gene-related peptide immunoreactive axons contacting dynorphin A(1-8) immunoreactive spinal neurons in a rat model of peripheral inflammation and hyperalgesia.

O Takahashi1, R J Traub, M A Ruda.   

Abstract

In a rat model of peripheral inflammation and hyperalgesia, dynorphin A(1-8)-like immunoreactive (DYN-LIr) spinal neurons were examined for contacts from calcitonin gene-related peptide-like immunoreactive (CGRP-LIr) varicosities using a double-label PAP method. Ipsilateral to the inflammation, CGRP-LIr varicosities contacted both dendrites and somata of DYN-LIr neurons in lumbar laminae I, II and V. Few such contacts were found on the contralateral side. The results suggest that opioid neurons which exhibit a dynamic change in dynorphin associated with inflammation, represent a subpopulation of neurons that receive contacts from presumptive nociceptive primary afferents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905620     DOI: 10.1016/0006-8993(88)90213-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 2.  The vanilloid agonist resiniferatoxin for interventional-based pain control.

Authors:  Michael J Iadarola; Andrew J Mannes
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply.

Authors:  S Kar; S J Gibson; R G Rees; W G Jura; D A Brewerton; J M Polak
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

4.  Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush.

Authors:  C Sommer; R R Myers
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.